• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症患者血清 GH 和 IGF-I 水平的性别差异及 GH 对动态试验的反应。

Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly.

机构信息

Department of Medicine, Institute of Clinical Endocrinology Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Endocr J. 2010;57(6):477-83. doi: 10.1507/endocrj.k09e-342. Epub 2010 Mar 4.

DOI:10.1507/endocrj.k09e-342
PMID:20203424
Abstract

Gender affects the GH secretory pattern both in normal subjects and in patients with acromegaly by an uncertain mechanism. Here, we report the influence of gender on the relationship between serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly. Seventy-four patients with untreated acromegaly (M/F 27/47, age range 22-86 yr.) were studied. The serum GH levels did not differ between male and female (6.1 vs. 8.7 ng/ml; p=0.26), while serum IGF-I levels, IGF-I SDS and the IGF-I/GH ratio were lower in female than those in male (679 vs. 769 ng/ml; p<0.02, 7.3 vs. 9.2 SDS; p<0.02 and 79.6 vs. 141.5; p<0.05). When the subjects were divided into two groups: age <or=50 yr, and age >50 yr, serum IGF-I levels and IGF-I/GH ratios were lower in female than those in male in patients <or=50 yrs (650 vs. 1002 ng/ml; p<0.05 and 59.8 vs. 142.9; p<0.05), but not in patients >50 yrs (684 vs. 680 ng/ml; p=0.39 and 98.7 vs. 118.4; p=0.40). The GH responses to OGTT, TRH, octreotide, and bromocriptine tests were similar in male and female. In conclusion, IGF-I/GH ratio was significantly lower in female than that in male particularly in younger patients with acromegaly. These data suggest that gender, presumably sex steroids in female, may partially modulate the relationship between circulating IGF-I and GH levels in patients with acromegaly.

摘要

性别通过不确定的机制影响正常人和肢端肥大症患者的 GH 分泌模式。在这里,我们报告性别对肢端肥大症患者血清 GH 和 IGF-I 水平之间的关系以及 GH 对动态试验的反应的影响。研究了 74 例未经治疗的肢端肥大症患者(M/F 27/47,年龄 22-86 岁)。男性和女性的血清 GH 水平没有差异(6.1 与 8.7ng/ml;p=0.26),而女性的血清 IGF-I 水平、IGF-I SDS 和 IGF-I/GH 比值低于男性(679 与 769ng/ml;p<0.02,7.3 与 9.2 SDS;p<0.02 和 79.6 与 141.5;p<0.05)。当将受试者分为两组:年龄<或=50 岁和年龄>50 岁时,年龄<或=50 岁的女性患者的血清 IGF-I 水平和 IGF-I/GH 比值低于男性(650 与 1002ng/ml;p<0.05 和 59.8 与 142.9;p<0.05),但年龄>50 岁的患者则没有(684 与 680ng/ml;p=0.39 和 98.7 与 118.4;p=0.40)。OGTT、TRH、奥曲肽和溴隐亭试验对 GH 的反应在男性和女性中相似。总之,女性的 IGF-I/GH 比值明显低于男性,尤其是在年轻的肢端肥大症患者中。这些数据表明,性别(可能是女性的性激素)可能部分调节了肢端肥大症患者循环 IGF-I 和 GH 水平之间的关系。

相似文献

1
Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly.肢端肥大症患者血清 GH 和 IGF-I 水平的性别差异及 GH 对动态试验的反应。
Endocr J. 2010;57(6):477-83. doi: 10.1507/endocrj.k09e-342. Epub 2010 Mar 4.
2
The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.肢端肥大症患者生长激素分泌对药物治疗的敏感性:年龄和性别的影响。
Clin Endocrinol (Oxf). 1992 Aug;37(2):181-5. doi: 10.1111/j.1365-2265.1992.tb02304.x.
3
[Lowered ghrelin levels in acromegaly—normalization after treatment].[肢端肥大症患者胃饥饿素水平降低——治疗后恢复正常]
Endokrynol Pol. 2005 Nov-Dec;56(6):862-70.
4
The relationship between serum GH and serum IGF-I in acromegaly is gender-specific.肢端肥大症患者血清生长激素(GH)与血清胰岛素样生长因子-I(IGF-I)之间的关系存在性别差异。
J Clin Endocrinol Metab. 2001 Nov;86(11):5240-4. doi: 10.1210/jcem.86.11.8006.
5
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.肢端肥大症患者术前对促甲状腺激素释放激素的生长激素反应及口服葡萄糖耐量试验:50例患者的回顾性评估
Metabolism. 2002 May;51(5):616-21. doi: 10.1053/meta.2002.32017.
6
Gender and age in the biochemical assessment of cure of acromegaly.肢端肥大症治愈的生化评估中的性别与年龄
Pituitary. 2001 Aug;4(3):163-71. doi: 10.1023/a:1015314906972.
7
Gender- and age-related differences in the endocrine parameters of acromegaly.肢端肥大症内分泌参数的性别和年龄相关差异。
J Endocrinol Invest. 2002 Jun;25(6):532-8. doi: 10.1007/BF03345496.
8
Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.术后促甲状腺素释放激素诱导的生长激素持续释放可预测肢端肥大症患者的复发情况。
Clin Endocrinol (Oxf). 2002 Mar;56(3):313-9. doi: 10.1046/j.1365-2265.2002.01465.x.
9
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.奥曲肽治疗1年对肢端肥大症患者心脏功能的影响。
J Clin Endocrinol Metab. 1999 Jan;84(1):17-23. doi: 10.1210/jcem.84.1.5368.
10
Bromocriptine, a dopamine agonist, increases growth hormone secretion in a patient with acromegaly.溴隐亭,一种多巴胺激动剂,可增加一名肢端肥大症患者的生长激素分泌。
Tohoku J Exp Med. 2014 Oct;234(2):129-35. doi: 10.1620/tjem.234.129.

引用本文的文献

1
A Theoretical Link Between the GH/IGF-1 Axis and Cytokine Family in Children: Current Knowledge and Future Perspectives.儿童生长激素/胰岛素样生长因子-1轴与细胞因子家族之间的理论联系:当前认知与未来展望
Children (Basel). 2025 Apr 11;12(4):495. doi: 10.3390/children12040495.
2
Serum concentrations of IGF-I/IGF-II as biomarkers of alcohol damage during foetal development and diagnostic markers of Foetal Alcohol Syndrome.血清 IGF-I/IGF-II 浓度作为胎儿发育过程中酒精损害的生物标志物和胎儿酒精综合征的诊断标志物。
Sci Rep. 2019 Feb 7;9(1):1562. doi: 10.1038/s41598-018-38041-0.
3
Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.
诊断时肢端肥大症的体征和症状:ACRO-POLIS 研究中的医生和患者观点。
Endocrine. 2019 Jan;63(1):120-129. doi: 10.1007/s12020-018-1764-4. Epub 2018 Sep 29.
4
Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.生长激素腺瘤的影像学参数与临床和分子特征的相关性。
Sci Rep. 2018 Apr 18;8(1):6173. doi: 10.1038/s41598-018-24260-y.